Dr. Coulibaly holds a MD degree from the Faculty of Medicine of Bamako (Mali), a Master of Public Health from the University of Alabama at Birmingham (US), and a PhD in Tropical Medicine from the Liverpool School of Tropical Medicine (UK). He currently leads the NTDs Research Unit of the NIH/NIAID International Center of Excellence in Research (ICER-Mali) and the Research and Training Department at the Dermatology Hospital of Bamako. He is member of several National NTDs boards in Mali including the Malian Onchocerciasis Experts Committee.
His research focuses mainly on lymphatic filariasis (LF) with clinical trials, immunological characteristics, and operational research on access to ivermectin, albendazole, and praziquantel. His research extends to other neglected tropical diseases such as schistosomiasis and onchocerciasis. His laboratory is the technical arm of the onchocerciasis, LF, and schistosomiasis control/elimination programs in Mali. He is teaching the Neglected Tropical Diseases Epidemiology and the Clinical Epidemiology classes for the Master of Public Health Program at the Faculty of Medicine of Bamako. He managed several research studies based on both qualitative and quantitative research methods. Dr. Coulibaly is the author or coauthor of over 50 papers and book chapters.